<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE GlossaryTerm >
<GlossaryTerm id="CDR0000455149"><TermName>talotrexin</TermName><TermPronunciation>(ta-loh-TREK-sin)</TermPronunciation><TermDefinition><DefinitionText>A substance that is being studied in the treatment of leukemia and some other types of cancer. It belongs to the family of drugs called antifolates.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></TermDefinition><MediaLink ref="CDR0000715230" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;talotrexin&quot;" language="en" id="_3"/><MediaLink ref="CDR0000715231" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;talotrexina&quot;" language="es" id="_4"/><SpanishTermName>talotrexina</SpanishTermName><SpanishTermDefinition><DefinitionText>Sustancia en estudio para el tratamiento de la leucemia y algunos otros tipos de c√°ncer. Es un tipo de antifolato.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></SpanishTermDefinition><DateFirstPublished>2006-08-24</DateFirstPublished></GlossaryTerm>
